A California state appeals court has recently pronounced Gilead Sciences as “morally blameworthy.” The court ruled that the company must confront a negligence claim brought forth by tens of thousands of patients. It has been claimed that Gilead Sciences prioritized maximizing profits over patient safety by setting aside a newer, purportedly safer HIV drug in favor of an older medication.
The court made the decision as part of a legal battle faced by Gilead Sciences, one of the leading pharmaceutical companies. While the company’s specific response to the ruling is not known at this time, the future will certainly prove critical for the company as it grapples with the claim’s wide-reaching potential consequences.
Legal professionals across the globe should follow these proceedings closely, as they could set a precedent, shaping future cases involving negligence claims against pharmaceutical companies.
For more detailed information on this developing story, visit Law360.